Alercell Is All Set to Launch a Leukemia Diagnostic Test Lena Q51(R)

Bozeman, MT, December 29, 2022 – (SEAPRWire) – Alercell is all set to launch LENA Q51(R) in January 2023. A leukemia diagnostic test based on sequencing DNA will detect up to 51 Genes mutations in Leukemia patients. Alercell is on a mission of making a significant difference in the fight against cancer by offering unique and precise diagnostic solutions... » read more

Broncus Holding Corporation Closed Series D Financing
Broncus Holding Corporation Closed Series D Financing

HONG KONG, Jan 28, 2021 – (ACN Newswire) – Broncus Holding Corporation (“Broncus”), a global leader in diagnostic and therapeutic technology for lung diseases, announced today the closing of a Series D round of funding led by FountainVest Partners. Other investors include Exome Asset Management, Summer Capital, and Valliance Capital. Broncus is dedicated to the... » read more

Broncus Closes Series C Financing
Broncus Closes Series C Financing

HONG KONG, Oct 14, 2020 – (ACN Newswire) – Broncus Holding Company (“Broncus”), a global leader in diagnostic and therapeutic technology for lung diseases, today announced the closing of a Series C round of funding led by Lake Bleu Capital, and including Baidu Capital, the venture arm of one of the world’s largest Internet and... » read more